Skip to main content

Table 2 Reasons for not seeking care in cannabis clinics among individuals who reported self-medication with cannabis in an online survey in Quebec from November 2020 to January 2021 (n = 489)

From: A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada

Reason

Genderab

Ageb

Type of cannabis use

Total

Men (n = 210)

Women (n = 213)

p-value

21-34 (n = 224)

> 34 (n = 214)

p-value

Medical only (n = 113)

Medical + recreational (n = 326)

p-value

Never received information

102 (48.57)

122 (57.28)

0.07

135 (60.27)

97 (45.33)

0.002

60 (53.10)

172 (52.76)

0.95

232 (52.85)

Complexity of the process

98 (46.67)

69 (32.39)

0.003

96 (42.86)

78 (36.45)

0.17

38 (33.63)

137 (42.02)

0.13

175 (39.86)

Difficulty accessing medical cannabis clinics

61 (29.05)

36 (16.90)

0.003

60 (26.80)

42 (19.63)

0.07

20 (17.70)

82 (25.15)

0.11

102 (23.23)

The delay before obtaining cannabis is too long

43 (20.48)

24 (11.27)

0.009

44 (19.64)

27 (12.62)

0.04

16 (14.16)

55 (16.87)

0.50

71 (16.17)

Higher price of cannabis

35 (16.67)

16 (7.51)

0.004

23 (10.27)

30 (14.02)

0.23

16 (14.16)

37 (11.35)

0.43

53 (12.07)

Poor customer service with the clinics

7 (3.33)

5 (2.35)

0.54

8 (3.57)

6 (2.80)

0.65

7 (6.19)

7 (2.15)

0.03

14 (3.19)

Not satisfied with the characteristics of products

24 (11.43)

10 (4.69)

0.01

17 (7.59)

20 (9.35)

0.51

12 (10.62)

25 (7.67)

0.33

37 (8.43)

The inability to choose the products yourself

41 (19.52)

39 (18.31)

0.75

49 (21.88)

34 (15.89)

0.07

16 (14.16)

67 (20.55)

0.13

83 (18.91)

Follow-up with a doctor does not suit me

45 (21.43)

38 (17.84)

0.35

53 (23.66)

36 (16.82)

0.07

11 (9.73)

78 (23.93)

0.001

89 (20.27)

Refusal of physician

13 (6.19)

22 (10.33)

0.12

14 (6.25)

21 (9.81)

0.16

11 (9.73)

24 (7.36)

0.42

35 (7.97)

Other reasonsc

21 (10.00)

21 (9.86)

0.96

20 (8.93)

23 (10.75)

0.52

15 (13.27)

28 (8.59)

0.15

43 (9.79)

  1. Comparisons between groups were made using chi-square tests and p-value calculated. A p-value <0.05 was considered as statistically significant
  2. aSixteen participants who reported other gender were not included in the stratification
  3. bFifty participants whose answer was “I don’t know” were not considered in the denominator, in addition to one missing for age categorization
  4. cOther reasons included the following: treated condition does not require a medical prescription (minor symptoms), in the process to obtain medical cannabis; no prescription, combine medical access with SQDC access, never engaged in the process/does not feel the need for a medical prescription, stigmatization by the healthcare system, legal access at SQDC thus no need to go in clinics, no clinic near their location